AK104 for Recurrent or Metastatic Vulvar Cancer
Clinical trial NCT05932212 · RECRUITING
Trial details
- NCT number
- NCT05932212
- Sponsor
- Akeso
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-25
- Primary completion
- 2025-12-15
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.